Skip to main content
Filing year 2024

ALLIANCE FOR CANCER GENE THERAPY INC

Stamford, Connecticut·EIN 06-1619523·NTEE T30 · Philanthropy, Voluntarism & Grantmaking Foundations·3
Total revenue
$3.1M
Total assets
$15.7M
Total expenses
$0
Reported officers
21
Mission

ACGT SUPPORTS HIGH-RISK, HIGH-REWARD SCIENTIFIC RESEARCH TO DEVELOP CANCER THERAPEUTICS THAT USE THE BODY'S OWN CELLS AND GENES AS A LIVING MEDICINE. BY ACCELERATING THIS RESEARCH, ACGT IS HELPING TO ADVANCE THERAPIES THAT ARE SIGNIFICANTLY MORE EFFECTIVE AND LESS TOXIC THAN CURRENT CANCER TREATMENTS SUCH AS CHEMOTHERAPY AND RADIATION.

Executive compensation, broken down

Form 990 · Schedule J · 2 reported individuals · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Chief Program Officer
officer (unspecified)
$273k
Chief Philanthropy Officer
key employee
$223k

Plus 19 unpaid individuals.

Browse compensation in Philanthropy, Voluntarism & Grantmaking

Climbed 7%
over 2 years

From $255k in 2022 to $273k in 2024.

$255k
2022
$276k
2023
$273k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.